Report Detail

Other COVID-19 Impact on Global Biosynthesis of Cannabinoids Market Size, Status and Forecast 2020-2026

  • RnM4017092
  • |
  • 08 June, 2020
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

This report focuses on the global Biosynthesis of Cannabinoids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosynthesis of Cannabinoids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals

Market segment by Type, the product can be split into
THC
CBD
Others
Market segment by Application, split into
Food Industry
Medical Industry
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biosynthesis of Cannabinoids status, future forecast, growth opportunity, key market and key players.
To present the Biosynthesis of Cannabinoids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biosynthesis of Cannabinoids are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biosynthesis of Cannabinoids Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 THC
    • 1.4.3 CBD
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Biosynthesis of Cannabinoids Market Share by Application: 2020 VS 2026
    • 1.5.2 Food Industry
    • 1.5.3 Medical Industry
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Biosynthesis of Cannabinoids Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Biosynthesis of Cannabinoids Industry
      • 1.6.1.1 Biosynthesis of Cannabinoids Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Biosynthesis of Cannabinoids Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Biosynthesis of Cannabinoids Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Biosynthesis of Cannabinoids Market Perspective (2015-2026)
  • 2.2 Biosynthesis of Cannabinoids Growth Trends by Regions
    • 2.2.1 Biosynthesis of Cannabinoids Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biosynthesis of Cannabinoids Historic Market Share by Regions (2018-2019)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Competition Landscape by Key Players

  • 3.1 Biosynthesis of Cannabinoids Revenue by Players (2019-2020)
  • 3.2 Biosynthesis of Cannabinoids Key Players Head office and Area Served
  • 3.3 Key Players Biosynthesis of Cannabinoids Product/Solution/Service
  • 3.4 Date of Enter into Biosynthesis of Cannabinoids Market
  • 3.5 Key Players Biosynthesis of Cannabinoids Funding/Investment Analysis
  • 3.6 Global Key Players Biosynthesis of Cannabinoids Valuation & Market Capitalization
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Global Biosynthesis of Cannabinoids Market Size by Type (2019-2026)

    5 Global Biosynthesis of Cannabinoids Market Size by Application (2019-2026)

      6 North America

      • 6.1 North America Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 6.2 Biosynthesis of Cannabinoids Key Players in North America (2019-2020)
      • 6.3 North America Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 6.4 North America Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      7 Europe

      • 7.1 Europe Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 7.2 Biosynthesis of Cannabinoids Key Players in Europe (2019-2020)
      • 7.3 Europe Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 7.4 Europe Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      8 China

      • 8.1 China Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 8.2 Biosynthesis of Cannabinoids Key Players in China (2019-2020)
      • 8.3 China Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 8.4 China Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      9 Japan

      • 9.1 Japan Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 9.2 Biosynthesis of Cannabinoids Key Players in Japan (2019-2020)
      • 9.3 Japan Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 9.4 Japan Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      10 Southeast Asia

      • 10.1 Southeast Asia Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 10.2 Biosynthesis of Cannabinoids Key Players in Southeast Asia (2019-2020)
      • 10.3 Southeast Asia Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 10.4 Southeast Asia Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      11 India

      • 11.1 India Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 11.2 Biosynthesis of Cannabinoids Key Players in India (2019-2020)
      • 11.3 India Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 11.4 India Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      12 Central & South America

      • 12.1 Central & South America Biosynthesis of Cannabinoids Market Forecast (2019-2026)
      • 12.2 Biosynthesis of Cannabinoids Key Players in Central & South America (2019-2020)
      • 12.3 Central & South America Biosynthesis of Cannabinoids Market Size by Type (2015-2020)
      • 12.4 Central & South America Biosynthesis of Cannabinoids Market Size by Application (2015-2020)

      13 Key Players Profiles

      • 13.1 Anandia Laboratories
        • 13.1.1 Anandia Laboratories Company Details
        • 13.1.2 Anandia Laboratories Business Overview and Its Total Revenue
        • 13.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
        • 13.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.1.5 Anandia Laboratories Recent Development
      • 13.2 Gingko Bioworks
        • 13.2.1 Gingko Bioworks Company Details
        • 13.2.2 Gingko Bioworks Business Overview and Its Total Revenue
        • 13.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
        • 13.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.2.5 Gingko Bioworks Recent Development
      • 13.3 Hyasynth Bio
        • 13.3.1 Hyasynth Bio Company Details
        • 13.3.2 Hyasynth Bio Business Overview and Its Total Revenue
        • 13.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
        • 13.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.3.5 Hyasynth Bio Recent Development
      • 13.4 InMed Pharmaceuticals
        • 13.4.1 InMed Pharmaceuticals Company Details
        • 13.4.2 InMed Pharmaceuticals Business Overview and Its Total Revenue
        • 13.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
        • 13.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.4.5 InMed Pharmaceuticals Recent Development
      • 13.5 Librede
        • 13.5.1 Librede Company Details
        • 13.5.2 Librede Business Overview and Its Total Revenue
        • 13.5.3 Librede Biosynthesis of Cannabinoids Introduction
        • 13.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.5.5 Librede Recent Development
      • 13.6 Renew Biopharma
        • 13.6.1 Renew Biopharma Company Details
        • 13.6.2 Renew Biopharma Business Overview and Its Total Revenue
        • 13.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
        • 13.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.6.5 Renew Biopharma Recent Development
      • 13.7 Cronos Group
        • 13.7.1 Cronos Group Company Details
        • 13.7.2 Cronos Group Business Overview and Its Total Revenue
        • 13.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
        • 13.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.7.5 Cronos Group Recent Development
      • 13.8 Organigram
        • 13.8.1 Organigram Company Details
        • 13.8.2 Organigram Business Overview and Its Total Revenue
        • 13.8.3 Organigram Biosynthesis of Cannabinoids Introduction
        • 13.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.8.5 Organigram Recent Development
      • 13.9 Teewinot Life Sciences
        • 13.9.1 Teewinot Life Sciences Company Details
        • 13.9.2 Teewinot Life Sciences Business Overview and Its Total Revenue
        • 13.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
        • 13.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.9.5 Teewinot Life Sciences Recent Development
      • 13.10 ICC International Cannabis Corp.
        • 13.10.1 ICC International Cannabis Corp. Company Details
        • 13.10.2 ICC International Cannabis Corp. Business Overview and Its Total Revenue
        • 13.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
        • 13.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 13.10.5 ICC International Cannabis Corp. Recent Development
      • 13.11 Biotii Technologies Corp.
        • 10.11.1 Biotii Technologies Corp. Company Details
        • 10.11.2 Biotii Technologies Corp. Business Overview and Its Total Revenue
        • 10.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
        • 10.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 10.11.5 Biotii Technologies Corp. Recent Development
      • 13.12 Bristol-Myers Squibb
        • 10.12.1 Bristol-Myers Squibb Company Details
        • 10.12.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
        • 10.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
        • 10.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 10.12.5 Bristol-Myers Squibb Recent Development
      • 13.13 Biogen Inc.
        • 10.13.1 Biogen Inc. Company Details
        • 10.13.2 Biogen Inc. Business Overview and Its Total Revenue
        • 10.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
        • 10.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 10.13.5 Biogen Inc. Recent Development
      • 13.14 GW Pharmaceuticals
        • 10.14.1 GW Pharmaceuticals Company Details
        • 10.14.2 GW Pharmaceuticals Business Overview and Its Total Revenue
        • 10.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
        • 10.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2020))
        • 10.14.5 GW Pharmaceuticals Recent Development

      14 Market Dynamics

      • 14.1 Drivers
      • 14.2 Challenges
      • 14.3 Porter’s Five Forces Analysis
      • 14.4 Market Ecosystem and Value Chain Analysis

      15 Key Findings in This Report

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on COVID-19 Impact on Global Biosynthesis of Cannabinoids. Industry analysis & Market Report on COVID-19 Impact on Global Biosynthesis of Cannabinoids is a syndicated market report, published as COVID-19 Impact on Global Biosynthesis of Cannabinoids Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biosynthesis of Cannabinoids market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,108.30
      4,662.45
      6,216.60
      3,623.10
      5,434.65
      7,246.20
      597,597.00
      896,395.50
      1,195,194.00
      325,416.00
      488,124.00
      650,832.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report